Orbital Therapeutics is thrilled to announce the successful closing of a $300,000,000 funding round, a milestone that marks a new chapter in the company’s journey as a trailblazer in RNA medicine. As a pioneering organization with a bold vision of defining the future of RNA medicines, Orbital Therapeutics is poised to revolutionize treatment paradigms across a range of human diseases. This significant capital infusion will be strategically allocated to accelerate the development of their innovative pipeline, driving forward clinical trials and deepening research efforts into novel therapeutic approaches that harness the power of RNA. With a steadfast mission to enhance global health by unleashing the full potential of RNA medicines, the company is committed to exploring previously uncharted scientific territory, where groundbreaking discoveries hold the promise of transforming lives. The newly raised funds will enable Orbital Therapeutics to invest in cutting-edge technology platforms and expand strategic partnerships, thereby catalyzing advancements in precision medicine. Moreover, this investment underscores the high level of confidence that investors have in the company’s vision and its capability to address pressing unmet medical needs. As the narrative of modern medicine continues to evolve, Orbital Therapeutics is leading the charge, providing renewed hope and opening doors to treatments that were once thought impossible. This funding milestone is not only a testament to the company’s innovative spirit but also a strong affirmation of the immense potential of RNA-based therapies to shape the future of healthcare on a global scale.
Orbital Therapeutics Raises $300M in Series A Funding, Pioneering the Future of RNA Medicines
Get the full Orbital Therapeutics company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
NVision Quantum Technologies
At NVision, we engineer quantum-powered medical imaging technologies that deliver deeper, more precise MRI data for researchers and clinicians. Our unique hyperpolarization device POLARIS enables fast, simple, scalable imaging of metabolism at the cellular level. With hyperpolarized MRI, we are paving the way for earlier detection, faster treatment assessment and better risk profiling in oncology, cardiology, neurology and beyond.
$38.0M Series b
today
코인원 Coinone
‘Bringing Blockchain into the World’ 코인원은 블록체인 기반의 종합 금융사를 지향하는 전문 기업입니다. 현재 국내 최대 규모의 가상자산 거래소인 코인원을 중심으로 가상자산 관리, 거래매칭엔진 등 블록체인 영역의 금융 및 기반 서비스를 제공하고 있습니다. 블록체인을 통한 효율적이고 공정한 금융 시장을 만들겠다는 목표로, 가상자산과 블록체인 업계를 선도하는 기업으로 발돋움하기 위한 여정을 계속해 나가고 있습니다. # 더 쉽고, 빠르고, 안전한 암호화폐 거래소. 코인원 https://coinone.co.kr/
$106.0M Unknown
today
Baymatob
Baymatob aims for a world where no mum experiences avoidable complications in pregnancy or birth or unnecessary birth trauma. Where clinicians are empowered with valuable insights to make the best decisions for their patients and their team. Where health systems save avoidable costs, allowing them to improve resourcing across maternal care. We strive for success as an Australian innovation business, building our local economy and deep-tech capabilities.
$6.5M Series a
today
ZERODRAG
Zerodrag is a pioneering force in the UAV sector, dedicated to delivering high-performance, Made in India drone products designed specifically for Unmanned Aerial Vehicles. Incubated at IIT Delhi, we specialize in the manufacturing of advanced Flight Controllers, Electronic Speed Controllers (ESCs), Receivers, Video Transmitters (VTX), and more, all engineered to meet the diverse needs of professionals and enthusiasts alike. We pride ourselves on our compatibility with leading software platforms such as Betaflight, Ardupilot, and Pixhawk, ensuring that our products seamlessly integrate into a variety of applications. Our innovative, modular designs include fully solderless options, making installation and customization easier than ever. With a strong commitment to quality, each product is backed by a 12-month warranty, underscoring our dedication to customer satisfaction. At Zerodrag, we emphasize secure communication and cutting-edge technology to enhance safety and reliability in UAV operations. Explore our offerings and discover how Zerodrag Technologies is shaping the future of drone technology, empowering users with the tools they need for success in an ever-evolving landscape.
$682.0K Seed
today
TIEA CONNECTORS PVT LTD
Research, Design, Development & Manufacturing of Connectors & Contact Solutions
$8.0M Series a
today
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | Baymatob Australia | Series a | $6.5M | today |
| 2 | TIEA CONNECTORS PVT LTD India | Series a | $8.0M | today |
| 3 |  Feldwerke Germany | Series a | $13.0M | today |
| 4 |  Endra Sweden | Series a | $50.0M | today |
| 5 |  Oak Hill Bio | Series a | $32.5M | today |